Additional investigation is warranted considering the influence of different TP53 mutation variants with loss-of-function, dominant-negative, and gain-of-function activity on the radioresistance and DNA damage response of HNSCC cell lines. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.